Increased frequency of specific locus mutation following human cytomegalovirus infection

Virology

Volumn 230, Issue 1, 1997, Pages 48-61

  Albrecht, Thomas ^a   Fons, Michael P ^a   Deng, Cheng Z ^a   Boldogh, Istvan ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; HUMAN; HUMAN CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS REPLICATION;

CRICETINAE; CRICETULUS GRISEUS; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0031592613     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8467     Document Type: Article

References (82)

1. AbuBakar S., Au W. W., Legator M. S., Albrecht T. Induction of chromosome aberrations and mitotic arrest by cytomegalovirus in human cells. Environ. Mol. Mut. 12:1988;409-420.
2. Akigg A., Wilkinson G. W. G., Oram J. D. The structure of the major immediate-early gene of human cytomegalovirus strain AD169. Virus Res. 2:1985;107-121.
3. Albrecht T., Rapp F. Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus. Virology. 55:1973;53-61.
4. Albrecht T., Weller T. H. Heterogeneous morphologic features of plaques induced by five strains of human cytomegalovirus. Am. J. Clin. Path. 73:1980;648-654.
5. Albrecht T., Boldogh I., Fons M. P., Deng C. Z. Receptor-initiated activation of cells and their oncogenes by herpes-family viruses. J. Invest. Dermatol. 98:1992;29S-35S.
6. Albrecht T., Boldogh I., Fons M. P., Lee C. H., AbuBakar S., Russell J. M., Au W. W. Cell-activation responses to cytomegalovirus infection: relationship to the phasing of CMV replication and to the induction of cellular damage. Subcell. Biochem. 15:1989;157-202.
7. Albrecht T., Nachtigal M., St Jeor S. C., Rapp F. Induction of cellular DNA synthesis and increased mitotic activity in Syrian hamster embryo cells abortively infected with human cytomegalovirus. J. Gen. Virol. 30:1976;167-174.
8. Albrecht T., St. Jeor S. C., Funk F. D., Rapp F. Multiplicity reactivation of human cytomegalovirus inactivated by ultraviolet light. Int. J. Radiat. Biol. 26:1974;445-454.
9. Barrett J. C., Anderson M. Molecular mechanisms of carcinogenesis in humans and rodents. Mol. Carc. 7:1993;1-13.
10. Boldogh I., AbuBakar S., Albrecht T. Activation of proto-oncogenes: An immediate early event in human cytomegalovirus infection. Science. 247:1990;561-564.
11. Boldogh I, Beth E., Huang E.-S., Kyalwazi S. K., Giraldo G. Kaposi's sarcoma. IV. Detection of CMV DNA, CMV RNA, and CMNA in tumor biopsies. Int. J. Cancer. 28:1981;469-474.
12. Boldogh I., Brichacek B., Gonczol E., Hirsch I., Vaczi L. Viral DNA sequences in human cytomegalovirus-transformed hamster cell line at low passage. Acta Microbiol. Hung. 32:1985a;160-166.
13. Boldogh I., Gonczol E., Gartner L., Vaczi L. Stimulation of host DNA synthesis and induction of early antigens by ultraviolet light-irradiated human cytomegalovirus. Arch. Virol. 58:1978a;289-299.
14. Boldogh I., Gonczol E., Gartner L., Vaczi L. Transformation of hamster embryo fibroblast cells by UV-irradiated human cytomegalovirus. Acta Microbiol. Acad. Sci. Hung. 25:1978b;269-275.
15. Boldogh I., Huang E.-S., Baskar J. F., Gergely L., Albrecht T. Oncogenic transformation by cellular DNA isolated from human cytomegalovirus-infected cells. Intervirology. 34:1992;62-73.
16. Boldogh I., Huang E.-S., Baskar J. F., Vaczi L. HCMV specific expression in HEL cells transformed byXba. Acta Microbiol. Hung. 32:1985b;167-173.
17. Boldogh I., Huang E.-S., Rady P., Arany I., Tyring S., Albrecht T. Alteration in the coding potential and expression of H-ras. Intervirology. 37:1994;321-329.
18. Bradley M. O., Bhuyan B., Francis M. C., Langenbach R., Peterson A., Huberman E. Mutagenesis by chemical agents in V79 Chinese hamster cells: A review and analysis of the literature. Mutat. Res. 87:1981;81-142.
19. Bresnahan W. A., Boldogh I., Thompson E. A., Albrecht T. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology. 224:1996;150-160.
20. Casto B. C. Enhancement of adenovirus transformation by treatment of hamster cells with ultraviolet irradiation, DNA base analogs, and dibenz(a)anthracene. Cancer Res. 33:1973;402-407.
21. Clarke P., Clements J. B. Mutagenesis occurring following infection with herpes simplex virus does not require virus replication. Virology. 182:1991;597-606.
22. Cha T. A., Tom E., Kemble G. W., Duke G. M., Mocarski E. S., Spaete R. R. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70:1996;78-83.
23. Choi K. S., Kim S.-J., Kim S. The retinoablastoma gene product negatively regulates transcriptional activation mediated by the human cytomegalovirus IE2 protein. Virology. 208:1995;450-456.
24. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
25. Deng C. Z., AbuBakar S., Fons M. P., Boldogh I., Albrecht T. Modulation of the frequency of human cytomegalovirus-induced chromosome aberrations by camptothecin. Virology. 189:1992a;397-401.
26. Deng C. Z., Abubakar S., Fons M. P., Boldogh I., Hokanson J., Au W. W., Albrecht T. Cytomegalovirus-enhanced induction of chromosome aberrations in human peripheral blood lymphocytes treated with potent genotoxic agents. Environ. Mut. 19:1992b;304-310.
27. Fons M. P., Graves K., Cavallo T., Pollard R., Albrecht T. Human cytomegalovirus: development and progression of nuclear inclusions by primary clinical isolates and laboratory-adapted strains. Proc. Soc. Exp. Biol. Med. 181:1986;416-422.
28. Furnari A. B., Poma E., Kowalik T. F., Huong S.-M., Huang E.-S. Human cytomegalovirus immediate-early gene 2 protein interacts with itself and with several novel cellular proteins. J. Virol. 67:1993;4981-4991.
29. Geder L., Lausch R., O'Neill F., Rapp F. Oncogenic transformation of human embryonic lung cells by human cytomegalovirus. Science. 192:1976;1134-1137.
30. Geissler E., Theile M. Virus-induced gene mutations of eukaryotic cells. Hum. Genet. 63:1983;1-12.
31. Giraldo G., Beth E., Henle W., Henle G., Mike V., Safai B., Huraux J. M., McHardy J., deThe G. Antibody patterns to herpesviruses in Kaposi's sarcoma. II. Serological association of American Kaposi's sarcoma with cytomegalovirus. Inter. J. Cancer. 22:1978;126-131.
32. Greenblatt M. S., Bennett W. P., Hollstein M., Harris C. C. Mutations inp53. Cancer Res. 54:1994;4855-4878.
33. Greenaway P. J., Wilkinson G. W. G. Nucleotide sequence of the most abundantly transcribed early gene of human cytomegalovirus strain AD169. Virus Res. 7:1987;17-31.
34. Grefte J. M. M., Van Der Giessen M., Van Der Gun B. T. F., Van Son W. J., The T. H. The predominant viral antigen present in peripheral blood leucocytes during an active cytomegalovirus (CMV) infection is the lower martix protein pp65. Progress in Cytomegalovirus Research. 1991;Excerpta Medica, Amsterdam. p. 233-236.
35. Hagemeier C., Caswell R., Hayhurst G., Sinclair J., Kouzarides T. Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J. 13:1994;2897-2903.
36. Hirai K., Defendi V., Diamond L. Enhancement of simian virus 40 transformation and integration by 4-nitroquinoline-1-oxide. Cancer Res. 34:1974;3497-3500.
37. Hsie A. W., Xu Z., Yu Y., An J., Meltz M. L., Schwartz J. L., Hrelia P. Quantitative and molecular analysis of genetic risk: a study with ionizing radiation. Environ. Health Perspect. 101:1993;213-218.
38. Huang E.-S., Boldogh I., Mar E.-C. Human cytomegalovirus: Evidence for possible association with human cancer. Fillips L. Viruses Associated with Human Cancer. 1983;161-194 Marcel Dekker, New York.
39. Hwang C. B. C., Shillitoe E. J. DNA sequence of mutations induced in cells by herpes simplex virus type-1. Virology. 178:1990;180-188.
40. Hwang C. B. C., Shillitoe E. J. Analysis of complex mutations induced in cells by herpes simplex virus type-1. Virology. 181:1991;620-629.
41. Jahan N., Razzaque A., Greenspan J., Connant M. A., Josephs S. F., Nakamura S., Rosenthal L. J. Analysis of human KS biopsies and cloned cell lines for cytomegalovirus, HIV-1, and other selected DNA virus sequences. AIDS Res. Hum. Retroviruses. 5:1989;225-231.
42. Jenkins D. E., Martens C. L., Mocarski E. S. Human cytomegalovirus late protein encoded byie2. J. Gen Virol. 75:1994;2337-2348.
43. -. Radiat. Res. 137:1994;371-379.
44. Kafatos F. C., Jones C. W., Efstratiadis A. Determination of nucleic acid sequence homologies and relative concentrations by a dot hybridization procedure. Nucleic Acids Res. 7:1979;1541-1552.
45. Kamiya S., Tanaka J., Ogura T., Ogura H., Sato H., Hatano M. Rabbit kidney cells abortively infected with human cytomegalovirus are arrested in mitotic phase. Arch. Virol. 89:1986;131-144.
46. Kouzarides T., Bankier A. T., Satchwell S. C., Weston K., Tomlinson P., Barrel B. G. Sequence and transcription analysis of the human cytomegalovirus DNA polymerase. J. Virol. 16:1987;125-133.
47. LaFauci G., Sapienza V. J., Chen C. J., Wisniewski H. M., Kim K. S. Expression of the human cytomegalovirus 65K tegument phosphoprotein in insect cells by baculovirus vectors. J. Gen. Virol. 75:1994;189-192.
48. Landini M. P., Ripalti A. A DNA-nicking activity associated with the nucleocapsid of human cytomegalovirus. Arch. Virol. 73:1982;351-356.
49. Li J. K. K., Dasker B., Kowalik L. Rapid alkaline blot-transfer of viral dsRNA. Anal. Biochem. 163:1987;214-216.
50. Maniatis T., Fritsch E. F., Sambrook J. Molecular Cloning: A Laboratory Manual. 1982;Cold Spring Harbor Laboratory, Cold Spring Harbor.
51. Marengo C., Mbikay M., Weber J., Thirion J.-P. Adenovirus-induced mutations at the hypoxanthine phosphoribosyltransferase locus of Chinese hamster cells. J. Virol. 38:1981;184-190.
52. Mazeron M. C., Jahn G., Plachter B. Monoclonal antibody E-13 (M-810) to human cytomegalovirus recognizes an epitope encoded by exon 2 of the major immediate early gene. J. Gen. Virol. 73:1992;2699-2703.
53. McConkey D. J., Hartzell P., Nicotera P., Orrenius S. Calcium-activated DNA fragmentation kills immature thymocytes. FASEB J. 3:1989;1843-1849.
54. McConkey D. J., Orrenius S., Jondal M. Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J. Immunol. 145:1990;1227-1230.
55. Melnick J. L., Lewis R., Wimberly I., Kaufman R. H., Adam E. Association of cytomegalovirus (CMV) infection with cervical cancer: Isolation of CMV from cell cultures derived from cervical biopsy. Intervirology. 10:1978;115-119.
56. D. Millinoff, 1992, Mechanism of papaverine-mediated inhibition of human cytomegalovirus replication, University of Texas Medical Branch, Galveston, Texas.
57. Milo G. E., Blakesless J. R., Hart R., Yohn D. S. Chemical carcinogen alteration of SV40-virus induced transformation of normal human cell populations in vitro. Chem. Biol. Interact. 22:1978;185-197.
58. Nelson J. A., Fleckenstein B., Galloway D. A., McDougall J. K. Transformation of NIH 3T3 cells with cloned fragments of human cytomegalovirus strain AD-169. J. Virol. 43:1982;83-91.
59. O'Neill J. P., Brimer P. A., Hirsch R., Hsie A. W. A quantitative assay of mutation induction at the hypoxanthine-guanine phosphoribosyl transferase locus in Chinese hamster ovary cells (CHO/HGPRT system): development and definition of the system. Mutat. Res. 45:1977;91-101.
60. Pilon L., Langelier Y., Royal A. Herpes simplex virus type 2 mutagenesis: Characterization of mutants induced at the hprt locus of nonpermissive XC cells. Mol. Cell. Biol. 6:1986;2977-2983.
61. Pilon L., Royal A., Langelier Y. Increased mutation frequency after herpes simplex virus type 2 infection in non-permissive XC cells. J. Gen. Virol. 66:1985;259-265.
62. Rapp F., Geder L., Murasko D., Lausch R., Ladda R., Huang E.-S., Webber M. J. Long-term persistence of cytomegalovirus genome in cultured human cells of prostatic origin. J. Urol. 16:1975;982-990.
63. Renan M. J. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol. Carc. 7:1993;139-146.
64. Rosenthal L. J., Choudhury S. Potential oncogenicity of human cytomegalovirus. Becker Y., Darai G. Molecular Aspects of Human Cytomegalovirus Diseases. 1993;412-436 Springer-Verlag, New York.
65. Rossiter B. J. F., Fuscoe J. C., Muzny D. M., Fox M., Caskey C. T. The Chinese hamster HPRT gene: restriction map, sequence analysis, and multiplex PCR deletion screen. Genomics. 9:1991;247-256.
66. Schlehofer J. R., zurHausen H. Induction of mutation within the host cell genome by partially inactivated herpes simplex virus type 1. Virology. 122:1982;471-475.
67. Schwartz J. L., Rotmensch J., Sun J., An J., Xu Z., Yu Y., Hsie A. W. Multiplex polymerase chain reaction-based deletion analysis of spontaneous, gamma ray- and alpha-induced hprt mutants of CHO-K1 cells. Mutagenesis. 9:1994;537-540.
68. Smiley M. L., Mar E.-C., Huang E.-S. Cytomegalovirus infection and viral-induced transformation of human endothelial cells. J. Med. Virol. 25:1988;213-226.
69. Sommer M. H., Scully A. L., Spector D. H. Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retininoblastoma protein. J. Virol. 68:1994;6223-6231.
70. Speir E., Modali R., Huang E.-S., Leon M. B., Shawl F., Finkel T., Epstein S. E. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 265:1994;391-394.
71. Staprans S. I., Spector D. H. 2.2-kilobase class of early transcripts encoded by cell-related sequences in human cytomegalovirus strain AD-169. J. Virol. 57:1986;591-602.
72. Stenberg R. M., Witte P. R., Stinski M. F. Multiple spliced and unspliced transcripts from human cytomegalovirus immediate early region 2 and evidence for a common initiation site within immediate early region 1. J. Virol. 56:1985;665-675.
73. Taylor H. P., Cooper N. R. Human cytomegalovirus binding to fibroblasts is receptor mediated. J. Virol. 63:1989;3991-3998.
74. Theile M., Krause H., Geissler E. Simian virus-induced mutagenesis: Action of the early viral region. J. Gen. Virol. 68:1987;233-237.
75. Theile M., Grabowski G. Mutagenic activity of BKV and JCV in human and other mammalian cells. Arch. Virol. 113:1990;221-233.
76. Theile M., Strauss M. Mutagenesis by simian virus 40. II. Changes in substrate affinities in mutant hypoxanthine-guanine phophoribosyl transferase enzymes at different pH values. Mutat. Res. 45:1977;111-123.
77. Tsai H.-L., Kou G.-H., Chen S.-C., Wu C.-W., Lin Y.-S. Human cytomegalovirus immediate-early protein IE2 tethers a transcriptional repression domain to p53. J. Biol. Chem. 271:1996;3534-3540.
78. Tsai C. H., Williams M. V., Glaser R. A monoclonal antibody that neutralizes Epstein-Barr virus, human cytomegalovirus, human herpesvirus 6, and bacteriophage T4 DNA polymerases. Proc. Natl. Acad. Sci. USA. 87:1990;7963-7967.
79. Wade M., Kowalik T. F., Mudryj M., Huang E.-S., Azizkhan J. C. E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection. Mol. Cell. Biol. 12:1992;4364-4374.
80. Weistein I. B. Synergistic interactions between chemical carcinogens, tumor promoters, and viruses and their relevance to human liver cancer. Cancer Detect. Prevent. 14:1989;253-259.
81. Xu Z., Yu Y., Gibbs R. A., Caskey T. C., Hsie A. W. Multiplex DNA amplification and solid-phase direct sequencing for mutational analysis of the hprt locus in Chinese hamster cells. Mutat. Res. 288:1993;237-248.
82. Yu Y.-J., Xu Z., Gibbs R. A., Hsie A. W. Polymerase chain reaction-based comprehensive procedure for the analysis of the mutation spectrum at the hypoxanthine-guanine phosphoribosyltransferase locus in Chinese hamster cells. Environ. Mol. Mutagen. 19:1992;267-273.